A Group Therapy Based on the Bio-psycho-social Treatment Approach for Women With Chronic Pelvic and Chronic Belly Pain

Sponsor
Swiss Paraplegic Centre Nottwil (Other)
Overall Status
Recruiting
CT.gov ID
NCT04057664
Collaborator
(none)
35
1
40
0.9

Study Details

Study Description

Brief Summary

The project investigates the situation of patients with chronic pelvic and chronic belly pain before and after our group therapy.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Learning of Coping Strategies

Detailed Description

To treat patients with chronic pelvic and belly pain in an interdisciplinary way, we developped a group therapy consisting of twelve sessions and a booster session. The therapy is based on the bio-psycho-social model of pain and includes group sessions of psychotherapy as well as physiotherapy.

All patients fill in questionnaires (concerning pain impact, pain chronicity, depression, anxiety, stress, well-being and sexuality) before and after the therapy as well as three and twelve months after.

Study Design

Study Type:
Observational
Anticipated Enrollment :
35 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Managing the Pain - a Group Therapy Based on the Bio-psycho-social Treatment Approach for Women With Chronic Pelvic Pain and Chronic Belly Pain
Actual Study Start Date :
Sep 1, 2020
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Multidisciplinary Group Therapy

Multidisciplinary group therapy for women with chronic pelvic or belly pain

Behavioral: Learning of Coping Strategies
Group sessions with psychotherapy and physiotherapy

Outcome Measures

Primary Outcome Measures

  1. Change in Pelvic Pain Impact Questionnaire (PPIQ) [baseline, 6 weeks, 3 months, 12 months]

    Self reported questionnaire with 8 questions to assess the impact of pelvic pain on quality of life, daily activities and emotional life. Each questions is scored 0-4, yielding a total from 0 and 32.

Secondary Outcome Measures

  1. Change in Sexual Functioning Questionnaire (CSFQ-14) [baseline, 6 weeks, 3 months, 12 months]

    Self-reported questionnaire with 14 questions assessing comorbidity- or medication-related sexual dysfunction. Each questions is scored using a 5-point Likert scale. Total scores range from 14 to 70, with lower scores indicating greater levels of sexual dysfunction.

  2. Change in Female Sexual Distress Scale-Revised (FSDS-R) [baseline, 6 weeks, 3 months, 12 months]

    Self-reported questionnaire assessing distress associated with sexual dysfunction. Each questions is scored using a 5-point Likert scale (0=never to 4=always). Total scores range from 0 to 52, with higher scores indicating greater levels of sexually related distress.

  3. Change in Chronic Pain Grade Scale (CPGS) [baseline, 6 weeks, 3 months, 12 months]

    Self-reported questionnaire with 3 questions assessing the presence of chronic pain at the site of injury. Each questions is scored using a 11-point Likert scale. Total scores range from 0 to 30, with higher scores indicating more pain.

  4. Change in Depression [baseline, 6 weeks, 3 months, 12 months]

    Subscale of Depression Anxiety and Stress Scale (DASS) questionnaire. Self-reported questionnaire with 14 questions assessing depression. Each questions is scored using a 4-point Likert scale (0=does not apply at all to 3=apply very much). Total sub-scores range from 0 to 42.

  5. Change in Anxiety [baseline, 6 weeks, 3 months, 12 months]

    Subscale of Depression Anxiety and Stress Scale (DASS) questionnaire. Self-reported questionnaire with 14 questions assessing anxiety. Each questions is scored using a 4-point Likert scale (0=does not apply at all to 3=apply very much). Total sub-scores range from 0 to 42.

  6. Change in Stress [baseline, 6 weeks, 3 months, 12 months]

    Subscale of Depression Anxiety and Stress Scale (DASS) questionnaire. Self-reported questionnaire with 14 questions assessing stress. Each questions is scored using a 4-point Likert scale (0=does not apply at all to 3=apply very much). Total sub-scores range from 0 to 42.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Women with chronic pelvic pain or belly pain participating in our group therapy who give their consent to the analysis of their data for the study

Exclusion Criteria:
  • No participation in the group therapy

  • Finishing the group therapy prematurely (>3 missed sessions)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center of Pain Medicine Nottwil LU Switzerland 6207

Sponsors and Collaborators

  • Swiss Paraplegic Centre Nottwil

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Swiss Paraplegic Centre Nottwil
ClinicalTrials.gov Identifier:
NCT04057664
Other Study ID Numbers:
  • 2018-28
First Posted:
Aug 15, 2019
Last Update Posted:
Jan 11, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Swiss Paraplegic Centre Nottwil
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2022